Trial reportBMC geriatrics2025
Effect of pharmacist-led medication reviews on appropriateness of prescribing in patients with dementia - results from the cluster randomized controlled "DemStepCare" study.
Trial report in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with dementia (PwD) are often geriatric patients treated with multimedication increasing the risk of drug-related problems (DRP) and inappropriate prescriptions. Pharmacist-led medication reviews are effective to solve DRPs and to improve medication appropriateness. The Medication Appropriateness Index (MAI) is a reliable, valid and standardised tool for detecting multiple dimensions of inappropriate prescribing. The research aimed to evaluate the impact of pharmacist-led medication reviews on medication appropriateness of PwDs as part of the DemStepCare study, using the MAI to categorise potentially inappropriate prescriptions.
methodsComprehensive medication reviews were performed for PwD treated as outpatients over 39 months in the longitudinal, cluster-randomized controlled DemStepCare study by a clinical pharmacist utilizing the project-specific, electronic patient record. Modified MAI scores were calculated at baseline and over the course of the study in the intervention group (IG) and control group (CG) at predefined time points. Only in the interventional arm, responsible GPs were informed about the result of the medication review and the pharmacist's recommendation to improve medication appropriateness.
results198 PwDs were enrolled in the IG and 47 PwDs in the CG (intention-to-treat collective). For IG patients, the modified MAI sum (SS) and patient score (PS) decreased significantly (p < 0.001) until t
conclusionEven a single comprehensive medication review significantly improved medication appropriateness in PwD. Based on the results, pharmacist-led medication reviews are strongly recommended for PwDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.